Risk factors for hidden metastatic lymph node on post I-131 ablation SPECT/CT in low and intermediate risk groups of papillary thyroid cancer

被引：0
|
作者：
Lee, Chang-Hee [1 ]
Jung, Ji-hoon [1 ]
Son, Seung Hyun [1 ]
Kim, Choon-Young [1 ]
Jeong, Shin Young [1 ]
Lee, Sang-Woo [1 ]
Lee, Jaetae [1 ]
Ahn, Byeong-Cheol [1 ]
机构：
[1] Kyungpook Natl Univ Hosp, Daegu, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
206
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer
    Lee, Chang-Hee
    Jung, Ji-Hoon
    Son, Seung Hyun
    Hong, Chae Moon
    Jeong, Ju Hye
    Jeong, Shin Young
    Lee, Sang-Woo
    Lee, Jaetae
    Ahn, Byeong-Cheol
    [J]. PLOS ONE, 2018, 13 (08):
  • [2] Lymph Node Metastases Identified at the Post-Ablation 131I SPECT/CT Scan Is a Prognostic Factor of Intermediate-Risk Papillary Thyroid Cancer
    Jia, Xi
    Wang, Yuanbo
    Yang, Lulu
    Fan, Kun
    Tao, Runyi
    Liu, Hui
    Yao, Xiaobao
    Yang, Aimin
    Zhang, Guangjian
    Gao, Rui
    [J]. DIAGNOSTICS, 2022, 12 (05)
  • [3] Factors Affecting Ablation Success After I-131 Radioactive Iodine Therapy in Low and Intermediate Risk Papillary Thyroid Cancer
    Goksel, Sibel
    Avci, Ugur
    [J]. HORMONE AND METABOLIC RESEARCH, 2023, 55 (10) : 677 - 683
  • [4] Risk factor for Persistent Metastatic Neck Lymph Nodes after I-131 Ablation Therapy in Papillary Thyroid Cancer
    Lee, Chang-Hee
    Jung, Ji-Hoon
    Kim, Choon-Young
    Son, Seung Hyun
    Jeong, Shin Young
    Lee, Sang-Woo
    Lee, Jaetae
    Ahn, Byeong-Cheol
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [5] The value of SPECT-CT in the post I-131 ablation evaluation of patients with thyroid cancer
    Tuncel, Murat
    Vatankulu, Betul
    Caglar, Meltem
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [6] Correlation analysis of I-131 SPECT/CT uptake parameters with the success ablation treatment of thyroid remnant in patients with low-intermediate-risk differentiated thyroid cancer
    Zhang, Qian
    Xu, Weina
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (10) : 1051 - 1057
  • [7] Rectus Abdominis Muscle Metastasis From Papillary Thyroid Cancer Identified by I-131 SPECT/CT
    Zhao, Li-xia
    Li, Lin
    Li, Fang-lan
    Zhao, Zhen
    [J]. CLINICAL NUCLEAR MEDICINE, 2010, 35 (05) : 360 - 361
  • [8] Comparing High and Low dose I-131 Therapy in Intermediate and Low Risk Differentiated Thyroid Cancer Patients
    Yasmin, T.
    Adnan, S.
    Younis, M. N.
    Shahid, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S664 - S665
  • [9] Post-therapy I-131 SPECT-CT in risk stratification and management of patients with differentiated thyroid cancer: A prospective study
    Agrawal, Kanhaiya
    Bhattacharya, Anish
    Kuruva, Manohar
    Harisankar, Cnb
    Kashyap, Karri
    Batchu, Suneetha
    Singh, Baljinder
    Mittal, Bhagwant
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [10] Clinical applications of SPECT/CT after first I-131 ablation in patients with differentiated thyroid cancer
    Jeong, Shin Young
    Lee, Sang-Woo
    Kim, Hae Won
    Song, Bong-Il
    Ahn, Byeong-Cheol
    Lee, Jaetae
    [J]. CLINICAL ENDOCRINOLOGY, 2014, 81 (03) : 445 - 451
12345